← Evidence map

TrialInflammatory bowel diseases2025

Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE Trial.

Dhruv Ahuja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE Trial. | OpenQuestion